Trials / Unknown
UnknownNCT00599469
Far Infrared Treatment for Alzheimer's Disease
Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Treatment of Alzheimer's Disease.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- GAAD Medical Research Institute Inc. · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Alzheimer's disease is a progressive and fatal brain disease. This study will investigate the use of far infrared radiation treatment for the disease.
Detailed description
Alzheimer's destroys brain cells, causing problems with memory, thinking and behaviour severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time and it is fatal. Alzheimer's, which has no current cure, is the most common form of dementia. It is hereby postulated that far infrared radiation of the central nervous and endocrine systems will help with the management of the disease and possibly cure the disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Far Infrared Radiation (5μm to 20μm wavelength) | Far Infrared radiation for 30 to 40 minutes per treatment session. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-03-01
- Completion
- 2009-04-01
- First posted
- 2008-01-23
- Last updated
- 2009-08-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00599469. Inclusion in this directory is not an endorsement.